Meeder Asset Management’s Haemonetics HAE Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $19.5K | Buy |
+261
| New | +$19.5K | ﹤0.01% | 524 |
|
2023
Q2 | – | Sell |
-155
| Closed | -$12.8K | – | 545 |
|
2023
Q1 | $12.8K | Sell |
155
-187
| -55% | -$15.5K | ﹤0.01% | 491 |
|
2022
Q4 | $26.9K | Buy |
342
+135
| +65% | +$10.6K | ﹤0.01% | 585 |
|
2022
Q3 | $15K | Buy |
207
+18
| +10% | +$1.3K | ﹤0.01% | 1191 |
|
2022
Q2 | $12K | Buy |
189
+58
| +44% | +$3.68K | ﹤0.01% | 1309 |
|
2022
Q1 | $8K | Buy |
131
+94
| +254% | +$5.74K | ﹤0.01% | 1632 |
|
2021
Q4 | $2K | Buy |
37
+15
| +68% | +$811 | ﹤0.01% | 976 |
|
2021
Q3 | $2K | Sell |
22
-23
| -51% | -$2.09K | ﹤0.01% | 2182 |
|
2021
Q2 | $3K | Sell |
45
-253
| -85% | -$16.9K | ﹤0.01% | 2100 |
|
2021
Q1 | $33K | Buy |
298
+294
| +7,350% | +$32.6K | ﹤0.01% | 1241 |
|
2020
Q4 | $0 | Hold |
4
| – | – | ﹤0.01% | 2020 |
|
2020
Q3 | $0 | Buy |
4
+2
| +100% | – | ﹤0.01% | 2255 |
|
2020
Q2 | $0 | Sell |
2
-979
| -100% | – | ﹤0.01% | 2215 |
|
2020
Q1 | $98K | Buy |
981
+280
| +40% | +$28K | 0.01% | 723 |
|
2019
Q4 | $81K | Sell |
701
-3,366
| -83% | -$389K | ﹤0.01% | 854 |
|
2019
Q3 | $512K | Buy |
+4,067
| New | +$512K | 0.03% | 400 |
|
2019
Q2 | – | Sell |
-144
| Closed | -$13K | – | 2073 |
|
2019
Q1 | $13K | Sell |
144
-345
| -71% | -$31.1K | ﹤0.01% | 1165 |
|
2018
Q4 | $50K | Buy |
489
+84
| +21% | +$8.59K | ﹤0.01% | 814 |
|
2018
Q3 | $46K | Sell |
405
-11,692
| -97% | -$1.33M | ﹤0.01% | 801 |
|
2018
Q2 | $1.08M | Buy |
12,097
+9,992
| +475% | +$896K | 0.09% | 194 |
|
2018
Q1 | $154K | Buy |
2,105
+220
| +12% | +$16.1K | 0.01% | 482 |
|
2017
Q4 | $110K | Buy |
1,885
+1,821
| +2,845% | +$106K | 0.01% | 549 |
|
2017
Q3 | $3K | Buy |
+64
| New | +$3K | ﹤0.01% | 1373 |
|